These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29571967)

  • 1. Functional mechanism of ASP5736, a selective serotonin 5-HT
    Yamazaki M; Yamamoto N; Yarimizu J; Okabe M; Moriyama A; Furutani M; Marcus MM; Svensson TH; Harada K
    Eur Neuropsychopharmacol; 2018 May; 28(5):620-629. PubMed ID: 29571967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASP5736, a novel 5-HT5A receptor antagonist, ameliorates positive symptoms and cognitive impairment in animal models of schizophrenia.
    Yamazaki M; Harada K; Yamamoto N; Yarimizu J; Okabe M; Shimada T; Ni K; Matsuoka N
    Eur Neuropsychopharmacol; 2014 Oct; 24(10):1698-708. PubMed ID: 25108314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 5-HT5A receptor antagonists ameliorate scopolamine-induced working memory deficit in mice and reference memory impairment in aged rats.
    Yamazaki M; Okabe M; Yamamoto N; Yarimizu J; Harada K
    J Pharmacol Sci; 2015 Mar; 127(3):362-9. PubMed ID: 25837935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia.
    Nikiforuk A; Hołuj M; Kos T; Popik P
    Neuropharmacology; 2016 Jun; 105():351-360. PubMed ID: 26826431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT5A Receptor Antagonist ASP5736 Ameliorates Several Abnormal Behaviors in an Fmr1-Targeted Transgenic Male Rat Model of Fragile X Syndrome.
    Yamazaki M; Arai T; Yarimizu J; Matsumoto M
    Int J Neuropsychopharmacol; 2022 Sep; 25(9):786-793. PubMed ID: 35882205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral lesion of the nigrostriatal pathway decreases the response of GABA interneurons in the dorsal raphe nucleus to 5-HT(1A) receptor stimulation in the rat.
    Hou C; Xue L; Feng J; Zhang L; Wang Y; Chen L; Wang T; Zhang QJ; Liu J
    Neurochem Int; 2012 Dec; 61(8):1344-56. PubMed ID: 23032407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected].
    Svensson TH; Mathé JM; Andersson JL; Nomikos GG; Hildebrand BE; Marcus M
    J Clin Psychopharmacol; 1995 Feb; 15(1 Suppl 1):11S-18S. PubMed ID: 7730496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medial prefrontal cortical output neurons to the ventral tegmental area (VTA) and their responses to burst-patterned stimulation of the VTA: neuroanatomical and in vivo electrophysiological analyses.
    Au-Young SM; Shen H; Yang CR
    Synapse; 1999 Dec; 34(4):245-55. PubMed ID: 10529719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential control of dopamine ascending pathways by serotonin2B receptor antagonists: New opportunities for the treatment of schizophrenia.
    Devroye C; Cathala A; Haddjeri N; Rovera R; Vallée M; Drago F; Piazza PV; Spampinato U
    Neuropharmacology; 2016 Oct; 109():59-68. PubMed ID: 27260325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.
    Lejeune F; Millan MJ
    Synapse; 1998 Oct; 30(2):172-80. PubMed ID: 9723787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
    Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
    Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons.
    Lladó-Pelfort L; Santana N; Ghisi V; Artigas F; Celada P
    Cereb Cortex; 2012 Jul; 22(7):1487-97. PubMed ID: 21893679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat.
    Harte M; O'Connor WT
    Brain Res; 2004 Aug; 1017(1-2):120-9. PubMed ID: 15261107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite control of mesocortical and mesoaccumbal dopamine pathways by serotonin
    Devroye C; Haddjeri N; Cathala A; Rovera R; Drago F; Piazza PV; Artigas F; Spampinato U
    Neuropharmacology; 2017 Jun; 119():91-99. PubMed ID: 28390892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral lesion of the nigrostriatal pathway decreases the response of fast-spiking interneurons in the medial prefrontal cortex to 5-HT1A receptor agonist and expression of the receptor in parvalbumin-positive neurons in the rat.
    Gui ZH; Zhang QJ; Liu J; Zhang L; Ali U; Hou C; Fan LL; Sun YN; Wu ZH; Hui YP
    Neurochem Int; 2011 Oct; 59(5):618-27. PubMed ID: 21693147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonist.
    Díaz-Mataix L; Artigas F; Celada P
    Eur Neuropsychopharmacol; 2006 May; 16(4):288-96. PubMed ID: 16290106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effects of activation and blockade of 5-HT(2A/2C) receptors in the firing activity of pyramidal neurons of medial prefrontal cortex in a rodent model of Parkinson's disease.
    Wang S; Zhang QJ; Liu J; Ali U; Wu ZH; Chen L; Gui ZH; Wang Y; Hui YP
    Exp Neurol; 2009 Sep; 219(1):239-48. PubMed ID: 19500571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid receptors in the prefrontal cortex regulate dopamine efflux to stress via descending glutamatergic feedback to the ventral tegmental area.
    Butts KA; Phillips AG
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1799-807. PubMed ID: 23590841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
    Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT
    Huang M; Kwon S; Rajagopal L; He W; Meltzer HY
    Psychopharmacology (Berl); 2018 Oct; 235(10):2795-2808. PubMed ID: 30066135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.